Toshiba's Opart Magnetic Resonance Imaging (MRI) cleared by FDA
This article was originally published in Clinica
Executive Summary
Toshiba America Medical Systems has received FDA clearance to market its Opart open, super-conducting MRI system. Opart's open design provides patient access from all four sides and allows scanning while the patient is still connected to ancillary MRI-compatible monitoring equipment. It also has a lateral moving table which facilitates patient positioning.